Literature DB >> 11312914

Mapping and fitting the peripheral benzodiazepine receptor binding site by carboxamide derivatives. Comparison of different approaches to quantitative ligand-receptor interaction modeling.

M Anzini1, A Cappelli, S Vomero, M Seeber, M C Menziani, T Langer, B Hagen, C Manzoni, J J Bourguignon.   

Abstract

The synthetic-computational approach to the study of the binding site of peripheral benzodiazepine receptor (PBR) ligands related to 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK11195, 1) within their receptor (Cappelli et al. J. Med. Chem. 1997, 40, 2910-2921) has been extended. A series of carboxamide derivatives endowed with differently substituted planar aromatic or heteroaromatic systems was designed with the aim of getting further information on the topological requisites of the carbonyl and aromatic moieties for interaction with the PBR binding site. The synthesis of most of these compounds involves Weinreb amidation of the appropriate lactone as the key step. The most potent compound, among the newly synthesized ones, shows a nanomolar PBR affinity similar to that shown by 1 and the presence of a basic N-ethyl-N-benzylaminomethyl group in 3-position of the quinoline nucleus. Thus, it may be considered the first example of a new class of water soluble derivatives of 1. Several computational methods were used to furnish descriptors of the isolated ligands (indirect approaches) able to rationalize the variation in the binding affinity of the enlarged series of compounds. Sound QSAR models are obtained by size and shape descriptors (volume approach) which codify for the short-range contributions to ligand-receptor interactions. Molecular descriptors which explicitly account for the electrostatic contribution to the interaction (CoMFA, CoMSIA, and surface approaches) perform well, but they do not improve the quantitative models. Moreover, useful hints for the identification of the antagonist binding site in the three-dimensional modeling of the receptor (direct approach) were provided by the receptor hypothesis derived by the pharmacophoric approach. The ligand-receptor complexes obtained provided a detailed description of the modalities of the interaction and interesting suggestions for further experiments.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312914     DOI: 10.1021/jm0009742

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Evaluating molecular similarity using reduced representations of the electron density.

Authors:  Nathalie Meurice; Gerald M Maggiora; Daniel P Vercauteren
Journal:  J Mol Model       Date:  2005-05-12       Impact factor: 1.810

Review 2.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.

Authors:  Rainer Rupprecht; Vassilios Papadopoulos; Gerhard Rammes; Thomas C Baghai; Jinjiang Fan; Nagaraju Akula; Ghislaine Groyer; David Adams; Michael Schumacher
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

3.  Oxone promoted dehydrogenative Povarov cyclization of N-aryl glycine derivatives: an approach towards quinoline fused lactones and lactams.

Authors:  Devidas A More; Ganesh H Shinde; Aslam C Shaikh; M Muthukrishnan
Journal:  RSC Adv       Date:  2019-09-25       Impact factor: 4.036

4.  Ethyl 2,6-dichloro-4-phenyl-quinoline-3-carboxyl-ate.

Authors:  S Mohana Roopan; F Nawaz Khan; M Vijetha; Venkatesha R Hathwar; Seik Weng Ng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-11-04

5.  Solution structures of the prototypical 18 kDa translocator protein ligand, PK 11195, elucidated with 1H/13C NMR spectroscopy and quantum chemistry.

Authors:  Yong-Sok Lee; Fabrice G Siméon; Emmanuelle Briard; Victor W Pike
Journal:  ACS Chem Neurosci       Date:  2012-02-14       Impact factor: 4.418

6.  Three-dimensional structure of TspO by electron cryomicroscopy of helical crystals.

Authors:  Vladimir M Korkhov; Carsten Sachse; Judith M Short; Christopher G Tate
Journal:  Structure       Date:  2010-06-09       Impact factor: 5.006

7.  TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy.

Authors:  Barbara Costa; Eleonora Da Pozzo; Chiara Giacomelli; Elisabetta Barresi; Sabrina Taliani; Federico Da Settimo; Claudia Martini
Journal:  Sci Rep       Date:  2016-01-11       Impact factor: 4.379

8.  A novel 18F-labelled high affinity agent for PET imaging of the translocator protein.

Authors:  Adele Blair; Filip Zmuda; Gaurav Malviya; Adriana A S Tavares; Gilles D Tamagnan; Anthony J Chalmers; Deborah Dewar; Sally L Pimlott; Andrew Sutherland
Journal:  Chem Sci       Date:  2015-05-27       Impact factor: 9.825

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.